CISPLATIN Accord 50 mg/50 ml conc perf 1 pce
7680668090037
CH-66809
L01XA01
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6680903
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- cisplatinum 50 mg, natrii chloridum, natrii hydroxidum, acidum hydrochloridum concentratum, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 177 mg.
Articles (1)
Cisplatin Accord 50 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
cisplatinum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum concentratum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
177.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 78.30
Specialties list
Yes
Generic
Yes
SL addition date:
01/09/2018
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66809
- Drug name
- Cisplatin Accord, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/06/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CISPLATIN Accord 50 mg/50 ml conc perf 1 pce
- Description (DE)
- CISPLATIN Accord 50 mg/50 ml Konz Inf 1 Stk
- Market launch
- 29/06/2018
- Narcotic (BTM)
- No